Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 31 of 31 publications.

Gnanasakthy A, Qin S, Norcross L. Editorial - FDA guidance on selecting, developing, or modifying fit-for-purpose clinical outcome assessments: old wine in a new bottle? Patient. 2023 Jan. doi: 10.1007/s40271-022-00607-6

Mansfield C, Bullok K, Fuhs JV, Tockhorn-Heidenreich A, Andrews JS, DiBenedetti D, Matthews BR, Darling JC, Sutphin J, Hauber B. The patient voice: exploring treatment preferences in participants with mild cognitive concerns to inform regulatory decision making. Patient. 2022 Sep;15(5):551-64. doi: 10.1007/s40271-022-00576-w

Vass CM, Barton A, Payne K. Towards personalising the use of biologics in rheumatoid arthritis: a discrete choice experiment. Patient. 2022 Jan;15(1):109-19. doi: 10.1007/s40271-021-00533-z

Gnanasakthy A. Editorial - FDA guidance on assessment of patient‑reported outcomes in cancer trials: a breath of fresh air or a storm in a teacup? Patient. 2021 Nov;14(6):695-7. doi: 10.1007/s40271-021-00542-y

Shields GE, Brown L, Wells A, Capobianco L, Vass C. Utilising patient and public involvement in stated preference research in health: learning from the existing literature and a case study. Patient. 2021 Jul;14(4):399-412. doi: 10.1007/s40271-020-00439-2

Vass CM, Boeri M, Poulos C, Turner AJ. Matching and weighting in health preference research. Presented at the 2021 Virtual 12th Meeting of the International Academy of Health Preference Research; June 2021. [abstract] Patient. 2021 Jun 18; p.1-6. doi: 10.1007/s40271-021-00532-0

Vass CM, Boeri M. Mobilising the next generation of stated-preference studies: the association of access device with choice behaviour and data quality. Patient. 2021 Jan;14(1):55-63. doi: 10.1007/s40271-020-00484-x

Doward LC, Balp M-M, Twiss J, Slota C, Cryer D, Brass CA, Anstee QM, Sanyal AJ. Development of a patient-reported outcome measure for non-alcoholic steatohepatitis (NASH-CHECK): results of a qualitative study. Patient. 2020 Dec 18. doi: 10.1007/s40271-020-00485-w

Hollin IL, Craig BM, Coast J, Beusterien K, Vass CM, DiSantostefano R, Peay H. Reporting formative qualitative research to support the development of quantitative preference study protocols and corresponding survey instruments: guidelines for authors and reviewers. Patient. 2020 Feb;13:121-36. doi: 10.1007/s40271-019-00401-x

Lewis S, Romano C, De Bruecker G, Murrough JW, Shelton R, Singh JB, Jamieson C. Analysis of clinical trial exit interview data in patients with treatment-resistant depression. Patient. 2019 Oct;12(5):527-37. doi: 10.1007/s40271-019-00369-8

Barrett A, Hahn-Pedersen J, Kragh N, Evans E, Gnanasakthy A. Patient-reported outcome measures in atopic dermatitis and chronic hand eczema in adults. Patient. 2019 Oct;12(5):445-9. doi: 10.1007/s40271-019-00373-y

Vass CM, Davison N, Vander Stichele G, Payne K. A picture is worth a thousand words: the role of survey training materials in stated-preference studies. Patient. 2019 Sep 30. doi: 10.1007/s40271-019-00391-w

Rigby D, Vass C, Payne K. Opening the 'Black Box': an overview of methods to investigate the decision-making process in choice-based surveys. Patient. 2019 Sep 5. doi: 10.1007/s40271-019-00385-8

Crawford R, Sully K, Conroy R, Johnson C, Doward L, Bell T, Welch V, Peloquin F, Gater A. Patient-centered insights on treatment decision making and living with acute myeloid leukemia and other hematologic cancers. Patient. 2019 Aug 28. doi: 10.1007/s40271-019-00384-9

Vass CM, Rigby D, Paynee K. “I was trying to do the maths”: exploring the impact of risk communication in discrete choice experiments. Patient. 2019 Feb;12(1):113-23. doi: 10.1007/s40271-018-0326-4

Mansfield C, Ekwueme DU, Tangka FKL, Brown DS, Smith JL, Guy, Jr GP, Li C, Hauber B. Colorectal cancer screening: preferences, past behavior, and future intentions. Patient. 2018 Nov 5;11(6):599-611. doi: 10.1007/s40271-018-0308-6

Wright SJ, Vass CM, Sim G, Burton M, Fiebig DG, Payne K. Accounting for scale heterogeneity in healthcare-related discrete choice experiments when comparing stated preferences: a systematic review. Patient. 2018 Oct;11(5):475-88. doi: 10.1007/s40271-018-0304-x

Vass CM, Wright S, Burton M, Payne K. Scale heterogeneity in healthcare discrete choice experiments: a primer. Patient. 2018 Apr;11(2):167-73. doi: 10.1007/s40271-017-0282-4

Meads DM, O'Dwyer JL, Hulme CT, Chintakayala P, Vinall-Collier K, Bennett MI. Patient preferences for pain management in advanced cancer: results from a discrete choice experiment. Patient. 2017 Oct;10(5):643-51. doi: 10.1007/s40271-017-0236-x

Winnette R, Hess LM, Nicol SJ, Tai DF, Copley-Merriman C. The patient experience with soft tissue sarcoma: a systematic review of the literature. Patient. 2017 Apr;10(2):153-62. doi: 10.1007/s40271-016-0200-1

Copley-Merriman C, Zelt S, Clark M, Gnanasakthy A. Impact of measuring patient-reported outcomes in dermatology drug development. Patient. 2017 Apr;10(2):203-13. doi: 10.1007/s40271-016-0196-6

Gray E, Eden M, Vass C, McAllister M, Louviere J, Payne K. Valuing preferences for the process and outcomes of clinical genetics services: a pilot study. Patient. 2016 Apr;9(2):135-47. doi: 10.1007/s40271-015-0133-0

Poulos C, Kinter E, Yang J-C, Bridges JFP, Posner JD, Reder AT. Patient preferences for injectable treatments for multiple sclerosis in the United States: a discrete-choice experiment. Patient. 2016 Apr;9(2):171-80. doi: 10.1007/s40271-015-0136-x

Mills A, Garner W, Pozniak A, Berenguer J, Speck RM, Bender R, Nguyen T. Patient-reported symptoms over 48 weeks in a randomized, open-label, phase IIIb non-inferiority trial of adults with HIV switching to co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir DF versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir DF. Patient. 2015 Aug;8(4):359-71. doi: 10.1007/s40271-015-0129-9

Harrison M, Rigby D, Vass C, Flynn T, Louviere J, Payne K. Risk as an attribute in discrete choice experiments: a systematic review of the literature. Patient. 2014 Jun;7(2):151-70. doi: 10.1007/s40271-014-0048-1

Nelson LM, Forsythe A, McLeod L, Pulgar S, Maldonado M, Coles T, Zhang Y, Webb SM, Badia X. Psychometric evaluation of the Cushing's Quality-of-Life Questionnaire. Patient. 2013 Apr 1;Advance Online.

Deal LS, Williams VSL, Fehnel SE. Development of an electronic daily uterine fibroid symptom diary. Patient. 2011 Jan 1;4(1):31-44.

Baldwin M, Spong A, Doward LC, Gnanasakthy A. Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyond. Patient. 2011 Jan;4(1):11-7. doi: 10.2165

Nathan RA, Dalal AA, Stanford RH, Meltzer EO, Schatz M, Derebery J, Mintz M, Thompson MA, DiBenedetti DB. Qualitative development of the rhinitis control assessment test (RCAT), an instrument for evaluating rhinitis symptom control. Patient. 2010 Jun 1;3(2):91-9.

Fehnel S, Zografos L, Curtice T, Shah H, McLeod L. The burden of restless legs syndrome: an assessment of work productivity, sleep, psychological distress, and health status among diagnosed and undiagnosed individuals in an internet-based panel. Patient. 2008 Jul 1;1(3):201-10.

Johnson FR, Mansfield CA. Survey-design and analytical strategies for better healthcare stated-choice studies. Patient. 2008;1(4):299-307.